Vaishali Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

10.55

10.55

10.55

10.55

6.59

Share application money

7.56

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

22.43

15.81

11.87

10.84

14.81

Loan funds

Secured loans

13.66

14.07

15.66

15.68

16.23

Unsecured loans

-

6.69

0.28

0.41

-

Total

54.20

47.12

38.35

37.47

37.63

Uses of funds

Fixed assets

Gross block

3.02

2.06

1.97

2.14

1.89

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1.04

0.88

0.75

0.65

0.55

Net block

1.98

1.18

1.22

1.49

1.34

Capital work-in-progress

0.67

0.49

0.05

0.08

0.04

Investments

0.43

0.43

0.43

0.43

0.43

Net current assets

Current assets, loans & advances

75.81

79.52

84.43

64.21

66.95

Less : current liabilities & provisions

24.70

34.51

47.77

28.74

31.12

Total net current assets

51.11

45.01

36.66

35.47

35.82

Miscellaneous expenses not written

-

-

-

-

-

Total

54.20

47.12

38.35

37.47

37.63

Notes:

Book value of unquoted investments

0.43

0.43

0.43

0.43

0.43

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

105.46

105.46

105.46

105.46

65.91